Allergan plc (AGN) was reiterated a ‘Buy’ by UBS analysts on Thursday. The broker however, cut its price target on the stock to $300 from $366.
AGN began trading this morning at $246.17 to currently trade 0.12% lower from the prior days close of $244.74. On an intraday basis it has gotten as low as $243.26 and as high as $246.75.
The $96.58 billion Dublin-based company has a median Street price target of $337.00 with a high target of $430.00. Allergan is down 17.19% year-over-year, compared with a 0.73% loss in the S&P 500.
The Walt Disney Company (DIS) was reiterated as ‘Neutral’ with a $102 from $96 price target on Thursday by Guggenheim following strong box office performance in the quarter.
Shares have traded today between $96.91 and $97.42 with the price of the stock fluctuating between $86.25 to $122.08 over the last 52 weeks.
Walt Disney Co. shares are currently changing hands at 18.14x this year’s forecasted earnings, compared to the industry’s 12.94x earnings multiple. Ticker has a t-12 price/sales ratio of 2.93. EPS for the same period registers at $5.35.
Shares of Disney have lost $0.40 to $97.08 in morning trading on Thursday, giving it a market cap of roughly $158.38 billion. The stock traded as high as $122.08 in August 4, 2015.
Equinix, Inc. (EQIX) rating of ‘Buy’ was reiterated today at Canaccord Genuity with a price target increase of $370 from $320 (versus a $327.41 previous close).
Shares of Equinix are down 0.76% at $324.93 as of this writing.
Shares of Global Payments Inc. (GPN) are up $1.05 to $71.91 in morning trading after Piper Jaffray reiterated its ‘Neutral’ rating and increased its 12-month base case estimate on the name by 3 points to $76 a share. GPN was also raised to $75 from $71 at Cowen following the Q3 report. The Atlanta-based company posted earnings of $0.70 per share on revenues of $497 million, up 6.2% from a year ago. Analysts were expecting EPS of $0.67 on revenues of $493.56 million.
For full fiscal year 2016, Global Payments provided EPS guidance of $2.93-$3.00 versus consensus of $2.94 per share.